Quick and Affordable Saliva-based COVID-19 Test Developed by Yale Scientists Receives FDA Emergency Use Authorization
A saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public Health to determine whether someone is infected with the novel coronavirus has been granted an emergency use authorization by the U.S. Food and Drug Administration (FDA).Source: YaleNews
Yale and NBA Partner to Study Efficacy of New COVID-19 Test
A research team led by Yale’s Nathan Grubaugh and Anne Wyllie will begin testing select players, coaches, and staff from the NBA teams that have opted into the study, using a testing method they developed, known as SalivaDirect. The results of the study are expected by the end of July and will be shared publicly.Source: YaleNews
The Washington Post and Yale School of Public Health form the Covid Counting Consortium (3C) to understand the impact of covid-19 on the U.S.
The Washington Post and the Yale School of Public Health today announced a partnership to form the Covid Counting Consortium (3C) to research and report on the impact of covid-19.Source: Washington Post
Yale team uses Google analytical tool to gauge vaccine effectiveness
Using a statistical method initially developed by Google, a Yale School of Public Health-led research team has devised a novel way to better analyze the impact of vaccines. The research was published in the Proceedings of the National Academy of Sciences.
New article in PLoS Medicine on association between RSV and pneumococcus
Check out our new article in PLOS Medicine on the association between RSV activity and pneumococcal disease in the US. With Keith Klugman (Emory/Gates), Lone Simonsen (GWU/U. Copenhagen), Claudia Steiner (AHRQ), and Cecile Viboud (NIH/Fogarty)Source: PLOS Medicine